Posted on 1/29/19
ZoomInfo Appoints Seth Low as CIO
WALTHAM, Mass.--(BUSINESS WIRE)--Zoom Information, Inc. (ZoomInfo), the leading data intelligence platform for sales and go-to-market organizations, is pleased to announce the appointment of Seth Low to . . .
Posted on 1/29/19
Harvard Pilgrim Health Care Selects OptumRx as Pharmacy Benefit Manager
WELLESLEY, Mass. & EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Harvard Pilgrim Health Care, a premier not-for-profit health services company, today announced it has entered into a new, multi-year agreement . . .
Posted on 1/29/19
Zipcar and Honda Expand Strategic Partnership
BOSTON, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Zipcar, the world’s leading car-sharing network, and Honda today announced an expansion of their strategic mobility partnership. The agreement . . .
Posted on 1/29/19
Eagle Bulk Shipping Closes $208M Credit Facility
Eagle Bulk Shipping Inc. (NASDAQ: EGLE) announced today that Eagle Bulk Ultraco LLC, a wholly-owned subsidiary of the Company,
Posted on 1/29/19
DLA Piper Advises CIRCOR in $85M Sale of Reliability Services Business to RelaDyne
DLA Piper represented CIRCOR International, Inc., a provider of flow control solutions and other highly
Posted on 1/28/19
NEI General Contracting Congratulates Mike Myers on Promotion to Project Executive
NEI General Contracting, an award-winning general contractor and construction management firm
Posted on 1/28/19
HFF Announces Sale of Nantasket Beach Resort in Hull, Massachusetts
Holliday Fenoglio Fowler, L.P. (HFF) announces the sale of the 107-room Nantasket Beach Resort in the suburban Boston-area community of Hull, Massachusetts. The HFF team represented . . .
Posted on 1/28/19
Shepley Bulfinch Celebrates Groundbreaking at Timber Lane Community Center
New building serves as gateway between neighborhoods and Cypress Creek Park (Photo courtesy of Shepley Bulfinch) Shepley Bulfinch, a national architecture firm with offices in Boston, . . .
Posted on 1/28/19
New Blood Test Helps Clinicians Identify Potentially Life-threatening Ara h 6 Peanut Sensitization
ImmunoCAP Specific IgE blood test for Ara h 6 is part of the line of component assays from Thermo Fisher Scientific that can differentiate between individual . . .
Posted on 1/28/19
Fertility Focus Raises $2.7 Million in Series A
Fertility Focus, a leading fertility monitoring technology company that is helping empower women who are struggling to conceive, has secured $2.7 million in its Series A . . .
Posted on 1/28/19
Indalo Therapeutics Appoints Robert Jacks CEO
Indalo Therapeutics, a biopharmaceutical company discovering and developing integrin antagonists for patients suffering from serious fibrotic diseases
Posted on 1/28/19
Curaleaf Expands Executive Leadership Team
Curaleaf Holdings, Inc. (CSE: CURA / OTCBB: CURLF), a leading vertically-integrated cannabis operator, today announced an expanded leadership team with two new executive appointments. Neil Davidson . . .
Posted on 1/28/19
ZeeVee Opens First Office in Southeast Asia
Accelerating its drive into Asia, ZeeVee (www.zeevee.com) has opened an office in Singapore, its first company facility in the Asia-Pacific region, to better serve the rapidly . . .
Posted on 1/28/19
Purdue Pharma and Alivio Therapeutics Enter into Partnership
STAMFORD, Conn. & BOSTON--(BUSINESS WIRE)--Purdue Pharma L.P. and Alivio Therapeutics today announced that they have entered into a partnership to advance one of Alivio’s product candidates through . . .
Posted on 1/28/19
TILT Holdings Announces Official Closing of Standard Farms Deal
CAMBRIDGE, Mass.--(BUSINESS WIRE)--TILT Holdings Inc. (CSE: TILT) (OTC: SVVTF), a global technology and infrastructure company engaged in the research, development, manufacturing and sale of a broad . . .
Posted on 1/28/19
CENTOGENE Expands Clinical Studies Team in U.S.
ROSTOCK, Germany--(BUSINESS WIRE)--CENTOGENE today announced the expansion of its clinical studies team, with the appointment of a number of clinical researchers to support its U.S. laboratory . . .
Posted on 1/28/19
PAREXEL Receives Consecutive Recognitions from Forbes and FlexJobs for its Workplace Culture
BOSTON--(BUSINESS WIRE)--PAREXEL International Corporation, a leading innovator of global biopharmaceutical services, today announced that the Company has once again been recognized for its diverse and flexible . . .
Posted on 1/28/19
New Energy Capital Infrastructure Credit Fund II Raises $500M
New Energy Capital Partners, LLC, a leading alternative asset management firm focused on debt and equity investments in small- and mid-sized clean energy infrastructure projects
Posted on 1/28/19
Lazard Asset Management Appoints Co-Heads of Sustainable Investment and ESG
NEW YORK & LONDON--(BUSINESS WIRE)--Lazard Asset Management LLC today announced that Jennifer Anderson and Nikita Singhal have joined the firm as Co-Heads of Sustainable Investment and . . .
Posted on 1/28/19
Entegris and Versum Materials To Combine In $9 Billion Merger of Equals
Entegris, Inc. (NASDAQ:ENTG), a leader in specialty chemicals and advanced materials solutions for the microelectronics industry, and Versum Materials, Inc.
Posted on 1/28/19
EyePoint Pharmaceuticals Appoints David Guyer, M.D., to Board of Directors
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products
Posted on 1/28/19
2019’s Best & Worst Cities for Football Fans
For many people, football is far more than just a game: it’s a sacred American tradition. These fans aren’t just spectators but are also participants. They . . .
Posted on 1/28/19
Is Bristol-Myers Squibb a Bargain Now?
It's been almost four years since a revolutionary new cancer therapy from Bristol-Myers Squibb (NYSE:BMY) became the first of its kind to treat lung cancer patients. . . .
Posted on 1/28/19
What Investors Should Look Out for When General Electric Reports Earnings
There's no way to sugarcoat this. The forthcoming earnings for General Electric(NYSE:GE) won't be pretty. The two segments set to be the core of the company . . .
Posted on 1/28/19
Bristol-Myers Squibb's Q4 Earnings Update Shows Why It Needs Celgene
Bristol-Myers Squibb (NYSE:BMY) reported very good fourth-quarter results on Thursday. Revenue jumped 10% year over year, with strong growth for blockbuster drugs Opdivo and Eliquis leading . . .
Boston
